Cargando…
In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19
COVID-19 was caused by a novel coronavirus known as SARS-CoV-2. The COVID-19 disease outbreak has been avowed as a global pandemic by the World Health Organization at the end of March 2020. It leads to the global economic crash, resulting in the starvation of a large population belonging to economic...
Autores principales: | Mujwar, Somdutt, Harwansh, Ranjit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046011/ https://www.ncbi.nlm.nih.gov/pubmed/35502321 http://dx.doi.org/10.1007/s11224-022-01943-x |
Ejemplares similares
-
Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2
por: Kciuk, Mateusz, et al.
Publicado: (2022) -
Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19
por: Jain, Rashi, et al.
Publicado: (2020) -
Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
por: Mujwar, Somdutt
Publicado: (2021) -
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
por: Eleftheriou, Phaedra, et al.
Publicado: (2020) -
In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)